UCB - Daily - Technical analysis published on 12/16/2024 (GMT)
- 90
- 0
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : TARGET REACHED
Summary of the analysis
Additional analysis
Quotes
UCB rating 183.00 EUR. The price registered an increase of +1.30% on the session and was traded between 181.35 EUR and 183.20 EUR over the period. The price is currently at +0.91% from its lowest and -0.11% from its highest.The Central Gaps scanner detects a bullish opening. A small advantage for buyers in the very short term.
Bullish opening
Type : Bullish
Timeframe : Openning
So that you have an overall view of the price change, here is a table showing the variations over several periods:
Near a new HIGH record (5 years)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1 year)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1st january)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
Technical
Technical analysis of this Daily chart of UCB indicates that the overall trend is strongly bullish. The signals given by the moving averages are 92.86% bullish. This strong bullish trend is confirmed by the strong signals currently being given by short-term moving averages. There is no crossing of moving average by the price or crossing of moving averages between themselves.
An assessment of technical indicators does not currently provide any relevant information on the direction of future price movements.
Other results related to technical indicators were also found by the Central Indicators scanner:
Pivot points : price is over resistance 1
Type : Neutral
Timeframe : Daily
Price is back over the pivot point
Type : Bullish
Timeframe : Weekly
Momentum indicator is back over 0
Type : Bullish
Timeframe : Daily
Central Patterns, the market scanner focusing on chart patterns, resistances and supports found this result:
Near support of channel
Type : Bullish
Timeframe : Daily
No result was found by the Central Candlesticks scanner on Japanese candlesticks.
S3 | S2 | S1 | Price | R1 | |
---|---|---|---|---|---|
ProTrendLines | 136.98 | 164.34 | 176.77 | 183.00 | 188.40 |
Change (%) | -25.15% | -10.20% | -3.40% | - | +2.95% |
Change | -46.02 | -18.66 | -6.23 | - | +5.40 |
Level | Minor | Major | Minor | - | Major |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 176.95 | 178.75 | 179.70 | 181.50 | 182.45 | 184.25 | 185.20 |
Camarilla | 179.89 | 180.15 | 180.40 | 180.65 | 180.90 | 181.15 | 181.41 |
Woodie | 176.53 | 178.54 | 179.28 | 181.29 | 182.03 | 184.04 | 184.78 |
Fibonacci | 178.75 | 179.80 | 180.45 | 181.50 | 182.55 | 183.20 | 184.25 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 170.42 | 174.78 | 177.72 | 182.08 | 185.02 | 189.38 | 192.32 |
Camarilla | 178.64 | 179.31 | 179.98 | 180.65 | 181.32 | 181.99 | 182.66 |
Woodie | 169.70 | 174.43 | 177.00 | 181.73 | 184.30 | 189.03 | 191.60 |
Fibonacci | 174.78 | 177.57 | 179.30 | 182.08 | 184.87 | 186.60 | 189.38 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 146.97 | 155.18 | 170.27 | 178.48 | 193.57 | 201.78 | 216.87 |
Camarilla | 178.94 | 181.08 | 183.21 | 185.35 | 187.49 | 189.62 | 191.76 |
Woodie | 150.40 | 156.90 | 173.70 | 180.20 | 197.00 | 203.50 | 220.30 |
Fibonacci | 155.18 | 164.08 | 169.58 | 178.48 | 187.38 | 192.88 | 201.78 |
Numerical data
The following are the details of the technical indicators and moving averages that were collected to generate this technical analysis:
RSI (14): | 54.40 | |
MACD (12,26,9): | 1.4300 | |
Directional Movement: | 3.00 | |
AROON (14): | -42.86 | |
DEMA (21): | 183.76 | |
Parabolic SAR (0,02-0,02-0,2): | 179.45 | |
Elder Ray (13): | 0.10 | |
Super Trend (3,10): | 175.18 | |
Zig ZAG (10): | 183.05 | |
VORTEX (21): | 1.1600 | |
Stochastique (14,3,5): | 23.98 | |
TEMA (21): | 182.96 | |
Williams %R (14): | -64.71 | |
Chande Momentum Oscillator (20): | 0.55 | |
Repulse (5,40,3): | -0.0100 | |
ROCnROLL: | 1 | |
TRIX (15,9): | 0.1600 | |
Courbe Coppock: | 4.47 |
MA7: | 181.86 | |
MA20: | 181.42 | |
MA50: | 178.04 | |
MA100: | 168.95 | |
MAexp7: | 182.18 | |
MAexp20: | 181.56 | |
MAexp50: | 177.12 | |
MAexp100: | 167.65 | |
Price / MA7: | +0.63% | |
Price / MA20: | +0.87% | |
Price / MA50: | +2.79% | |
Price / MA100: | +8.32% | |
Price / MAexp7: | +0.45% | |
Price / MAexp20: | +0.79% | |
Price / MAexp50: | +3.32% | |
Price / MAexp100: | +9.16% |
News
The last news published on UCB at the time of the generation of this analysis was as follows:
- UCB Presents New Data on Impact and Burden of Epilepsy at 2024 American Epilepsy Society (AES) Annual Meeting
- UCB presents latest scientific research in epilepsy at American Epilepsy Society (AES) Annual Meeting
- UCB Receives U.S. FDA Approval for BIMZELX® (bimekizumab-bkzx) as the First IL-17A and IL-17F Inhibitor for Adults with Moderate-to-Severe Hidradenitis Suppurativa
- New BIMZELX® (bimekizumab-bkzx) Data at ACR Convergence 2024 Highlights UCB's Efforts to Deliver Differentiated Care for Patients with Psoriatic Arthritis and Axial Spondyloarthritis
- UCB showcases new data for gMG management at the 2024 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting and Myasthenia Gravis Foundation of America (MGFA) Scientific Session
Add a comment
Comments
0 comments on the analysis UCB - Daily